LFCR logo

Lifecore Biomedical (LFCR) Cash From Operations

Annual CFO

-$217.00 K
+$17.22 M+98.76%

May 26, 2024


Summary


Performance

LFCR Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLFCRcash flowmetrics:

Quarterly CFO

-$6.11 M
-$5.47 M-850.23%

November 24, 2024


Summary


Performance

LFCR Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLFCRcash flowmetrics:

TTM CFO

$71.00 K
-$7.40 M-99.05%

November 24, 2024


Summary


Performance

LFCR TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLFCRcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

LFCR Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+98.8%0.0%0.0%
3 y3 years-101.3%0.0%0.0%
5 y5 years-101.3%0.0%0.0%

LFCR Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-101.3%+99.0%-170.7%+65.6%-99.0%+100.3%
5 y5-year-101.3%+99.0%-135.9%+65.6%-99.6%+100.3%
alltimeall time-100.7%+99.0%-133.4%+65.6%-99.8%+100.3%

Lifecore Biomedical Cash From Operations History

DateAnnualQuarterlyTTM
Nov 2024
-
-$6.11 M(+850.2%)
$71.00 K(-99.0%)
Aug 2024
-
-$643.00 K(-107.4%)
$7.47 M(-3541.9%)
May 2024
-$217.00 K(-98.8%)
$8.64 M(-575.8%)
-$217.00 K(-98.0%)
Feb 2024
-
-$1.82 M(-241.0%)
-$11.12 M(-47.1%)
Nov 2023
-
$1.29 M(-115.5%)
-$21.03 M(-14.8%)
Aug 2023
-
-$8.33 M(+268.2%)
-$24.67 M(+41.4%)
May 2023
-$17.44 M(-22.8%)
-$2.26 M(-80.7%)
-$17.44 M(+10.9%)
Feb 2023
-
-$11.72 M(+398.3%)
-$15.73 M(-27.7%)
Nov 2022
-
-$2.35 M(+113.7%)
-$21.74 M(-11.4%)
Aug 2022
-
-$1.10 M(+100.9%)
-$24.52 M(+8.6%)
May 2022
-$22.59 M(-237.2%)
-$548.00 K(-96.9%)
-$22.59 M(+39.7%)
Feb 2022
-
-$17.74 M(+245.3%)
-$16.17 M(+157.1%)
Nov 2021
-
-$5.14 M(-718.2%)
-$6.29 M(-2338.8%)
Aug 2021
-
$831.00 K(-85.8%)
$281.00 K(-98.3%)
May 2021
$16.47 M(-196.7%)
-
-
May 2021
-
$5.87 M(-174.7%)
$16.47 M(-883.2%)
Feb 2021
-
-$7.86 M(-647.5%)
-$2.10 M(-112.9%)
Nov 2020
-
$1.44 M(-91.6%)
$16.34 M(+201.5%)
Aug 2020
-
$17.02 M(-234.0%)
$5.42 M(-131.8%)
May 2020
-$17.04 M(-206.4%)
-$12.70 M(-220.0%)
-$17.04 M(+195.5%)
Feb 2020
-
$10.58 M(-211.6%)
-$5.77 M(+55.7%)
Nov 2019
-
-$9.48 M(+74.4%)
-$3.71 M(-144.1%)
Aug 2019
-
-$5.44 M(+280.6%)
$8.39 M(-47.6%)
May 2019
$16.02 M(-19.0%)
-$1.43 M(-111.3%)
$16.02 M(-5.4%)
Feb 2019
-
$12.65 M(+383.2%)
$16.93 M(-7.2%)
Nov 2018
-
$2.62 M(+19.7%)
$18.25 M(-1.5%)
Aug 2018
-
$2.19 M(-519.6%)
$18.52 M(-6.4%)
May 2018
$19.78 M(-33.7%)
-$521.00 K(-103.7%)
$19.78 M(-26.6%)
Feb 2018
-
$13.96 M(+383.9%)
$26.96 M(-12.0%)
Nov 2017
-
$2.89 M(-16.3%)
$30.65 M(+14.3%)
Aug 2017
-
$3.45 M(-48.2%)
$26.82 M(-10.1%)
May 2017
$29.84 M(+43.7%)
$6.66 M(-62.3%)
$29.84 M(-20.5%)
Feb 2017
-
$17.65 M(-1978.1%)
$37.51 M(+56.3%)
Nov 2016
-
-$940.00 K(-114.5%)
$24.01 M(-17.2%)
Aug 2016
-
$6.47 M(-54.9%)
$28.99 M(+39.6%)
May 2016
$20.76 M(-22.0%)
$14.33 M(+245.5%)
$20.76 M(+5.5%)
Feb 2016
-
$4.15 M(+2.5%)
$19.67 M(-23.0%)
Nov 2015
-
$4.05 M(-329.3%)
$25.55 M(+22.2%)
Aug 2015
-
-$1.76 M(-113.3%)
$20.91 M(-21.4%)
May 2015
$26.62 M(+26.5%)
$13.24 M(+32.1%)
$26.62 M(+29.3%)
Feb 2015
-
$10.03 M(-1790.7%)
$20.59 M(+2.4%)
Nov 2014
-
-$593.00 K(-115.0%)
$20.10 M(-1.7%)
Aug 2014
-
$3.94 M(-45.3%)
$20.45 M(-2.8%)
May 2014
$21.05 M(-0.9%)
$7.21 M(-24.4%)
$21.05 M(-2.5%)
Feb 2014
-
$9.54 M(-3994.3%)
$21.59 M(-6.7%)
Nov 2013
-
-$245.00 K(-105.4%)
$23.14 M(+11.9%)
Aug 2013
-
$4.54 M(-41.5%)
$20.68 M(-2.6%)
May 2013
$21.23 M(-4.3%)
$7.75 M(-30.1%)
$21.23 M(-21.7%)
Feb 2013
-
$11.09 M(-510.6%)
$27.12 M(+7.2%)
Nov 2012
-
-$2.70 M(-153.1%)
$25.31 M(+10.5%)
Aug 2012
-
$5.08 M(-62.7%)
$22.91 M(+3.3%)
May 2012
$22.18 M(+53.3%)
$13.65 M(+47.1%)
$22.18 M(+109.8%)
Feb 2012
-
$9.28 M(-281.9%)
$10.57 M(-9.3%)
Nov 2011
-
-$5.10 M(-217.0%)
$11.66 M(-19.3%)
Aug 2011
-
$4.36 M(+114.2%)
$14.44 M(-0.2%)
May 2011
$14.47 M
$2.04 M(-80.4%)
$14.47 M(+12.7%)
Feb 2011
-
$10.37 M(-547.8%)
$12.84 M(+140.3%)
DateAnnualQuarterlyTTM
Nov 2010
-
-$2.31 M(-152.8%)
$5.34 M(-29.6%)
Aug 2010
-
$4.38 M(+987.6%)
$7.59 M(+1.4%)
May 2010
$7.48 M(-20.7%)
$403.00 K(-86.0%)
$7.48 M(-26.7%)
Feb 2010
-
$2.87 M(-4323.5%)
$10.20 M(-1.7%)
Nov 2009
-
-$68.00 K(-101.6%)
$10.38 M(-10.2%)
Aug 2009
-
$4.28 M(+36.9%)
$11.56 M(+22.5%)
May 2009
$9.44 M(-46.1%)
$3.12 M(+2.4%)
$9.44 M(-23.8%)
Feb 2009
-
$3.05 M(+175.4%)
$12.38 M(-22.6%)
Nov 2008
-
$1.11 M(-48.5%)
$16.01 M(+3.2%)
Aug 2008
-
$2.15 M(-64.6%)
$15.52 M(-11.4%)
May 2008
$17.52 M(-949.7%)
$6.07 M(-9.1%)
$17.52 M(+5.7%)
Feb 2008
-
$6.68 M(+982.0%)
$16.57 M(+71.4%)
Nov 2007
-
$617.00 K(-85.2%)
$9.67 M(+140.4%)
Aug 2007
-
$4.16 M(-18.8%)
$4.02 M(-295.0%)
May 2007
-$2.06 M(-119.0%)
$5.12 M(-2346.1%)
-$2.06 M(-54.9%)
Feb 2007
-
-$228.00 K(-95.5%)
-$4.57 M(-132.8%)
Nov 2006
-
-$5.03 M(+161.1%)
$13.92 M(+24.5%)
Aug 2006
-
-$1.93 M(-173.8%)
$11.18 M(+2.9%)
May 2006
$10.87 M(-16.7%)
$2.61 M(-85.7%)
$10.87 M(+17.8%)
Feb 2006
-
$18.27 M(-335.1%)
$9.22 M(+98.0%)
Nov 2005
-
-$7.77 M(+246.7%)
$4.66 M(-59.6%)
Aug 2005
-
-$2.24 M(-331.0%)
$11.52 M(-11.7%)
May 2005
$13.05 M(+73.7%)
$970.00 K(-92.9%)
$13.05 M(+1.1%)
Feb 2005
-
$13.70 M(-1607.2%)
$12.91 M(+20.3%)
Nov 2004
-
-$909.00 K(+27.5%)
$10.73 M(+95.3%)
Aug 2004
-
-$713.00 K(-185.5%)
$5.50 M(-26.8%)
May 2004
$7.51 M(+251.1%)
$834.00 K(-92.8%)
$7.51 M(+6.5%)
Feb 2004
-
$11.52 M(-287.4%)
$7.05 M(-303.5%)
Nov 2003
-
-$6.15 M(-571.8%)
-$3.46 M(+396.4%)
Aug 2003
-
$1.30 M(+246.5%)
-$698.00 K(-82.9%)
May 2003
$2.14 M(-2217.8%)
-
-
Apr 2003
-
$376.00 K(-62.5%)
-$4.08 M(-47.0%)
Jan 2003
-
$1.00 M(-129.7%)
-$7.69 M(+7516.8%)
Oct 2002
-$101.00 K(-98.7%)
-$3.38 M(+62.6%)
-$101.00 K(-103.0%)
Jul 2002
-
-$2.08 M(-35.8%)
$3.40 M(-10.0%)
Apr 2002
-
-$3.24 M(-137.7%)
$3.78 M(-38.9%)
Jan 2002
-
$8.60 M(+6776.0%)
$6.19 M(-181.8%)
Oct 2001
-$7.57 M(-275.8%)
$125.00 K(-107.3%)
-$7.57 M(+46.4%)
Jul 2001
-
-$1.70 M(+105.4%)
-$5.17 M(+126.7%)
Apr 2001
-
-$828.00 K(-84.0%)
-$2.28 M(+5.7%)
Jan 2001
-
-$5.17 M(-304.6%)
-$2.16 M(-150.1%)
Oct 2000
$4.31 M(-216.5%)
$2.52 M(+112.5%)
$4.31 M(+141.2%)
Jul 2000
-
$1.19 M(-268.3%)
$1.78 M(-211.4%)
Apr 2000
-
-$706.00 K(-154.3%)
-$1.60 M(+7.1%)
Jan 2000
-
$1.30 M(>+9900.0%)
-$1.50 M(-59.5%)
Oct 1999
-$3.70 M(+8.7%)
$3000.00(-100.1%)
-$3.70 M(-9.8%)
Jul 1999
-
-$2.20 M(+266.7%)
-$4.10 M(-8.9%)
Apr 1999
-
-$600.00 K(-33.3%)
-$4.50 M(-19.6%)
Jan 1999
-
-$900.00 K(+125.0%)
-$5.60 M(+64.7%)
Oct 1998
-$3.40 M(-38.2%)
-$400.00 K(-84.6%)
-$3.40 M(-26.1%)
Jul 1998
-
-$2.60 M(+52.9%)
-$4.60 M(+39.4%)
Apr 1998
-
-$1.70 M(-230.8%)
-$3.30 M(+13.8%)
Jan 1998
-
$1.30 M(-181.3%)
-$2.90 M(-47.3%)
Oct 1997
-$5.50 M(+52.8%)
-$1.60 M(+23.1%)
-$5.50 M(+41.0%)
Jul 1997
-
-$1.30 M(0.0%)
-$3.90 M(+50.0%)
Apr 1997
-
-$1.30 M(0.0%)
-$2.60 M(+100.0%)
Jan 1997
-
-$1.30 M
-$1.30 M
Oct 1996
-$3.60 M
-
-

FAQ

  • What is Lifecore Biomedical annual cash flow from operations?
  • What is the all time high annual CFO for Lifecore Biomedical?
  • What is Lifecore Biomedical annual CFO year-on-year change?
  • What is Lifecore Biomedical quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Lifecore Biomedical?
  • What is Lifecore Biomedical quarterly CFO year-on-year change?
  • What is Lifecore Biomedical TTM cash flow from operations?
  • What is the all time high TTM CFO for Lifecore Biomedical?
  • What is Lifecore Biomedical TTM CFO year-on-year change?

What is Lifecore Biomedical annual cash flow from operations?

The current annual CFO of LFCR is -$217.00 K

What is the all time high annual CFO for Lifecore Biomedical?

Lifecore Biomedical all-time high annual cash flow from operations is $29.84 M

What is Lifecore Biomedical annual CFO year-on-year change?

Over the past year, LFCR annual cash flow from operations has changed by +$17.22 M (+98.76%)

What is Lifecore Biomedical quarterly cash flow from operations?

The current quarterly CFO of LFCR is -$6.11 M

What is the all time high quarterly CFO for Lifecore Biomedical?

Lifecore Biomedical all-time high quarterly cash flow from operations is $18.27 M

What is Lifecore Biomedical quarterly CFO year-on-year change?

Over the past year, LFCR quarterly cash flow from operations has changed by $0.00 (0.00%)

What is Lifecore Biomedical TTM cash flow from operations?

The current TTM CFO of LFCR is $71.00 K

What is the all time high TTM CFO for Lifecore Biomedical?

Lifecore Biomedical all-time high TTM cash flow from operations is $37.51 M

What is Lifecore Biomedical TTM CFO year-on-year change?

Over the past year, LFCR TTM cash flow from operations has changed by $0.00 (0.00%)